Remiges Ventures
Atsushi has been engaged in research and development of DDS technology for nucleic acid drugs for 16 years at a bio-venture company and experienced a series of processes from basic research and development to clinical trials for the creation of nucleic acid drugs. He was mainly in charge of pharmacodynamics in non-clinical studies. In addition, he managed PD marker measurement in clinical trials.
This person is not in any offices
Remiges Ventures
Remiges Ventures creates new companies based on intellectual properties from the Japanese academia. They create companies based on innovative science and seed products, manage the company formation stage with their own team and move the product development towards the Series A stage.